Annexon ANNX
NASDAQ ANNX
$4.87 +0.03 (+0.62%)
As of: Sep 4, 2026 · 3:59 PM EDT

Annexon (ANNX) Other Accumulated Expenses (2019 - 2026)

Annexon (ANNX) posted quarterly Other Accumulated Expenses of $11.0 million for Q1 2026, up 4508.37% year-over-year from $239000.0 in Q1 2025, and down 32.37% quarter-over-quarter from $16.3 million in Q4 2025.

Analysis

Annexon (ANNX) Other Accumulated Expenses (2019 - 2026) Analysis & Trends

Annexon's Other Accumulated Expenses history runs 8 years deep, the most recent figure standing at $11.0 million for Q1 2026.

  • In Q1 2026, Other Accumulated Expenses rose 4508.37% year-over-year to $11.0 million; the TTM figure through Mar 2026 stood at $11.0 million (up 4508.37% YoY), while the FY2025 annual figure was $16.3 million, up 11449.65% from the prior year.
  • Other Accumulated Expenses for Q1 2026 stood at $11.0 million, down from $16.3 million in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $16.3 million in Q4 2025, with the low at $79000.0 in Q3 2023.
  • The 5-year median for Other Accumulated Expenses is $164000.0 (2022), against an average of $3.3 million.
  • The sharpest annual moves came in 2022 and 2025: Other Accumulated Expenses plunged 94.82% in 2022, then jumped 11449.65% in 2025.
  • Annexon's Other Accumulated Expenses stood at $180000.0 in 2022, then fell by 21.67% to $141000.0 in 2023, then changed by 0.0% to $141000.0 in 2024, then surged by 11449.65% to $16.3 million in 2025, then slumped by 32.37% to $11.0 million in 2026.
  • Business Quant data shows ANNX's Other Accumulated Expenses at $11.0 million in Q1 2026, $16.3 million in Q4 2025, and $15.8 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Annexon 982.93 Mn 982.93 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.94 Mn
Mar 31, 2026 11.01 Mn
Dec 31, 2025 16.29 Mn
Sep 30, 2025 15.76 Mn
Jun 30, 2025 21.68 Mn
Mar 31, 2025 17.41 Mn
Dec 31, 2024 10.99 Mn
Sep 30, 2024 4.70 Mn
Jun 30, 2024 6.54 Mn
Mar 31, 2024 4.53 Mn
Dec 31, 2023 4.03 Mn
Sep 30, 2023 5.27 Mn
Jun 30, 2023 5.46 Mn
Mar 31, 2023 7.51 Mn
Dec 31, 2022 7.72 Mn
Sep 30, 2022 7.05 Mn
Jun 30, 2022 4.16 Mn
Mar 31, 2022 3.74 Mn
Dec 31, 2021 2.40 Mn
Sep 30, 2021 3.17 Mn